TRISCEND II: Top Late Breaking Trial at PCR London Valves 2024

PCR Highlights

Summary

Chiara De Biase and Raj Makkar share key insights from the TRISCEND II study. This innovative research addresses a crucial question: can transcatheter tricuspid valve replacement improve symptoms, quality of life, and clinical outcomes in patients? Listen as Makkar details the enrolled population and the study's transformative findings which demonstrates that TTVR was superior to medical therapy for the primary composite outcome in adults with symptomatic severe TR

This interview was filmed at PCR London Valves 2024: see more videos here.